PharmAust Progresses to Elevated Doses in MND Patients
PharmAust Progresses to Elevated Doses of MPL in MND Patients
PharmAust Progresses to Elevated Doses of MPL in MND Patients
https://www.pharmaust.com/wp-content/uploads/2023/01/Fireside-chat-with-Roger.mp4
MND Trial Completes Enrolment of First Patient Cohort (final)
https://www.pharmaust.com/wp-content/uploads/2022/12/Fireside-chat-with-Dr-Kim-edited.mp4
PharmAust canine trial update (final) clarification
PharmAust Receives R&D Tax Incentive Refund
MND Trial Completes Enrolment of First Patient Cohort (final)
Morgans Healthcare Research – PAA
https://www.pharmaust.com/wp-content/uploads/2022/11/PharmAust-Webinar.mp4